4//SEC Filing
Oesterle Stephen N. 4
Accession 0001104659-20-132938
CIK 0001821323other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 5:48 PM ET
Size
5.5 KB
Accession
0001104659-20-132938
Insider Transaction Report
Form 4
OESTERLE STEPHEN N
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-12-03+8,888→ 8,888 totalExercise: $18.00Exp: 2030-12-02→ Common Stock (8,888 underlying)
Footnotes (1)
- [F1]The option was issued pursuant to the Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan. The option will vest as to 100% on the earlier of July 14, 2021 or the Company's next annual meeting of stockholders.
Documents
Issuer
Sigilon Therapeutics, Inc.
CIK 0001821323
Entity typeother
Related Parties
1- filerCIK 0001174532
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 5:48 PM ET
- Size
- 5.5 KB